U.S. regulators have approved the first generic nasal spray version of Narcan, a drug that reverses opioid overdoses. The Food and Drug Administration on Friday OK’d naloxone spray from Israel’s Teva Pharmaceuticals. Naloxone has been sold as a nasal spray in the U.S. since 2016 under the brand name Narcan. Pharmacists can dispense it without […]
This story is from The Seattle Times. Read the rest of this News story at https://www.seattletimes.com/business/fda-oks-1st-generic-nasal-spray-of-overdose-reversal-drug/?utm_source=RSS&utm_medium=Referral&utm_campaign=RSS_seattle-news.